{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:47:21Z","timestamp":1781520441627,"version":"3.54.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:00:00Z","timestamp":1718668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ymgmr.2024.101110","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T09:44:39Z","timestamp":1718963079000},"page":"101110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pre-analytic decrease of phenylalanine in plasma of patients with phenylketonuria treated with pegvaliase"],"prefix":"10.1016","volume":"40","author":[{"given":"Coleman","family":"Turgeon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Casas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Peck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisele Bentz","family":"Pino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April Studinski","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitar","family":"Gavrilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin","family":"Oglesbee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Tortorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich","family":"Matern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia L.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2024.101110_bb0005","series-title":"GeneReviews(\u00ae)","article-title":"Phenylalanine Hydroxylase Deficiency","author":"Regier","year":"1993"},{"key":"10.1016\/j.ymgmr.2024.101110_bb0010","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1517\/17425255.2013.804064","article-title":"Sapropterin dihydrochloride for the treatment of hyperphenylalaninemias","volume":"9","author":"Blau","year":"2013","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ymgmr.2024.101110_bb0015","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ymgme.2011.12.023","article-title":"Evolving patient selection and clinical benefit criteria for sapropterin dihydrochloride (Kuvan\u00ae) treatment of PKU patients","volume":"105","author":"Gordon","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2024.101110_bb0020","article-title":"Use of pegvaliase in the management of phenylketonuria: case series of early experience in US clinics","volume":"28","author":"Adams","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgmr.2024.101110_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.108122","article-title":"Evaluating change in diet with pegvaliase treatment in adults with phenylketonuria: analysis of phase 3 clinical trial data","volume":"141","author":"Rohr","year":"2024","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2024.101110_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.108114","article-title":"Long-term comparative effectiveness of pegvaliase versus medical nutrition therapy with and without sapropterin in adults with phenylketonuria","volume":"141","author":"Burton","year":"2024","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2024.101110_bb0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13023-020-01391-y","article-title":"PKU dietary handbook to accompany PKU guidelines","volume":"15","author":"MacDonald","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2024.101110_bb0040","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.clinbiochem.2016.07.008","article-title":"Validation of amino-acids measurement in dried blood spot by FIA-MS\/MS for PKU management","volume":"49","author":"Bruno","year":"2016","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ymgmr.2024.101110_bb0045","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/jimd.12163","article-title":"Performance of laboratory tests used to measure blood phenylalanine for the monitoring of patients with phenylketonuria","volume":"43","author":"Moat","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2024.101110_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11100680","article-title":"Differences of phenylalanine concentrations in dried blood spots and in plasma: erythrocytes as a neglected component for this observation","volume":"11","author":"Haas","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.ymgmr.2024.101110_bb0055","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13023-017-0685-2","article-title":"The complete European guidelines on phenylketonuria: diagnosis and treatment","volume":"12","author":"van Wegberg","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"issue":"Suppl","key":"10.1016\/j.ymgmr.2024.101110_bb0060","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.ymgme.2013.10.006","article-title":"Man made disease: clinical manifestations of low phenylalanine levels in an inadequately treated phenylketonuria patient and mouse study","volume":"110","author":"Pode-Shakked","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2024.101110_bb0065","series-title":"Pegvaliase-Pqpz (Subcutaneous Route)","volume":"vol. 2024","year":"2024"},{"key":"10.1016\/j.ymgmr.2024.101110_bb0070","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1021\/acssensors.3c01384","article-title":"Fully integrated point-of-care platform for the self-monitoring of phenylalanine in finger-prick blood","volume":"8","author":"Messina","year":"2023","journal-title":"ACS Sens"},{"key":"10.1016\/j.ymgmr.2024.101110_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108361","article-title":"Satisfaction with home blood sampling methods and expectations for future point-of-care testing in phenylketonuria: perspectives from patients and professionals","volume":"142","author":"Kuypers","year":"2024","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2024.101110_bb0080","article-title":"A method for phenylalanine self-monitoring using phenylalanine ammonia-lyase and a pre-existing portable ammonia detection system","volume":"35","author":"Wada","year":"2023","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgmr.2024.101110_bb0085","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13023-023-02751-0","article-title":"Nutrition management of PKU with pegvaliase therapy: update of the web-based PKU nutrition management guideline recommendations","volume":"18","author":"Cunningham","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2024.101110_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107737","article-title":"Best practice recommendations for the management of anxiety during the pegvaliase journey","volume":"141","author":"Bjoraker","year":"2024","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2024.101110_bb0095","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/s41436-018-0403-z","article-title":"Evidence- and consensus-based recommendations for the use of pegvaliase in adults with phenylketonuria","volume":"21","author":"Longo","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgmr.2024.101110_bb0100","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.tem.2021.03.003","article-title":"Amino acid depletion therapies: starving cancer cells to death","volume":"32","author":"Butler","year":"2021","journal-title":"Trends Endocrinol. Metab."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426924000636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426924000636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T19:35:25Z","timestamp":1723923325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426924000636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":20,"alternative-id":["S2214426924000636"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2024.101110","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-analytic decrease of phenylalanine in plasma of patients with phenylketonuria treated with pegvaliase","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2024.101110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101110"}}